Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	The Journal of Infection in Developing Countries 2024-05-01
سلاسل:	Journal of Infection in Developing Countries
الموضوعات:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
الوصول للمادة أونلاين:	https://jidc.org/index.php/journal/article/view/18410
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!